Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saliva allergen specific IgG4 as biomarker for AIT efficacy
ChiCTR-OIN-16009909Phase 4Recruiting
- Sponsor
- East China Normal University Wuhu Affiliated Hospital
- Start
- Nov 2016
- Modality
- Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Der p Alutard SQ in allergic rhinitis (AR) and asthma (2 arms), sponsored by East China Normal University Wuhu Affiliated Hospital. Started Nov 2016; status: recruiting.
02
Drugs
Der p Alutard SQ
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on ChiCTR-OIN-16009909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-16009909.